Dan Blat PhD

Dan Blat joined Immunocore in 2014 and he currently serves as a senior scientist-manager in the pre-clinical biology group, where he leads a team of scientists whose main activities include pre-clinical testing of drug candidates, assay development and more recently integrating the CRISPR technology into Immunocore’s drug screening and research platforms. Dan holds a PhD in Immunology from the Weizmann Institute of Science, where he developed CAR-redirected regulatory T cells as treatment for autoimmune diseases.